Medical Center And Dispensaries Based Reporting

Objectives	- To enhance reporting from the ambulatory health system - To monitor communicable diseases by time, place and person - To detect alerts and outbreaks at local level
Sources of data	- Medical centers and dispensaries of the Ministry of Public Healht MOPH - Medical centers and dispensaries of the Ministry of Social Affairs MOSA - Other governemental medical centers and dispensaries - Medical centers and dispensaries of various Non-Governemetal Organizations NGO - Field medical units
Target diseases and syndromes	- Vaccine preventable diseases: acute flaccid paralysis, measles, rubella, pertussis (whooping cough) and mumps - For other communicable diseases: acute diarrhea, bloody/dysenteric diarrhea, cholera, acute jaundice, acute respiratory infection (including flu-like illness), unexplained fever, scabies and leishmania - Others: asthma, accidents/injuries
Guidelines	Medical center and dispensaries based surveillance guideline: Ar, En
Reporting form	Weekly reporting form
Results	- Latest weekly national bulletin

ATC	Name	B/G	Ingredients	Dosage	Form	Price
C04AX21	NAFTIPRAX	B	Naftidrofuryl hydrogen oxalate - 200mg	200mg	Tablet, film coated	614,328 L.L
D10AF05	NADIXA	G	Nadifloxacin - 1%	1%	Cream	850,652 L.L
D10AF05	NAXIDERM	G	Nadifloxacin - 1%	1%	Gel	826,783 L.L
R01AD09	NASONEX	B	Mometasone furoate (monohydrate) - 50mcg/dose	0.05%	Spray, suspension	529,474 L.L
H02AB04	NEPHARED	G	Methylprednisolone sodium succinate - 40mg	40mg	Injectable powder for solution	188,138 L.L
H02AB04	NEPHARED	G	Methylprednisolone sodium succinate - 125mg	125mg	Injectable powder for solution	469,001 L.L
L01XG03	NINLARO	B	Ixazomib - 4mg	4mg	Capsule, hard	388,991,058 L.L
L01XG03	NINLARO	B	Ixazomib - 3mg	3mg	Capsule, hard	348,420,676 L.L
L01XG03	NINLARO	B	Ixazomib - 2.3mg	2.3mg	Capsule, hard	272,619,919 L.L
A10AD05	NOVOMIX 30	BioTech	Insulin aspart - 30%, Insulin aspart protamine - 70%	100IU/ml	Injectable suspension	4,264,012 L.L
A10AD05	NOVOMIX 30	BioTech	Insulin aspart - 30%, Insulin aspart protamine - 70%	100IU/ml	Injectable suspension	4,264,012 L.L
A10AD05	NOVOMIX 30	BioTech	Insulin aspart - 30%, Insulin aspart protamine - 70%	100IU/ml	Injectable suspension	4,264,012 L.L
A10AB05	NOVORAPID FLEXPEN	BioTech	Insulin aspart - 100IU/ml	100IU/ml	Injectable solution	3,123,090 L.L
A10AB05	NOVORAPID FLEXPEN	BioTech	Insulin aspart - 100IU/ml	100IU/ml	Injectable solution	3,123,090 L.L
A10AB05	NOVORAPID FLEXPEN	BioTech	Insulin aspart - 100IU/ml	100IU/ml	Injectable solution	3,123,090 L.L
M01AE01	NORFEN 400	G	Ibuprofen - 400mg	400mg	Tablet, film coated	173,356 L.L
C01DA02	NITRODERM TTS 5	B	Glyceryl trinitrate - 5mg/24h	5mg/24h	Patch	599,511 L.L
N03AX12	NEUROPLEX	G	Gabapentin - 400mg	400mg	Capsule	1,290,089 L.L
N03AX12	NEUROPLEX	G	Gabapentin - 300mg	300mg	Capsule	1,107,326 L.L
N06AB03	NEANXETIN	G	Fluoxetine (HCl) - 20mg	20mg	Capsule	422,351 L.L
L03AA02	NIVESTIM	BioTech	Filgrastim - 30MIU/0.5ml	30MIU/0.5ml	Injectable solution	17,110,745 L.L
L03AA02	NEUTROMAX	BioTech	Filgrastim - 300mcg/ml	300mcg/ml	Injectable solution	2,553,301 L.L
L03AA02	NEOGRASTIM 30	BioTech	Filgrastim - 300mcg/ml	300mcg/ml	Injectable solution	1,970,969 L.L
L03AA02	NEUPOGEN	BioTech	Filgrastim - 300mcg/0.5ml	300mcg/0.5ml	Injectable solution	5,250,393 L.L
C10AB05	NANOFIB	G	Fenofibrate - 145mg	145mg	Tablet, film coated	1,371,615 L.L
G02BA	NUVARING	B	Etonogestrel - 0.12mg/day, Ethinylestradiol - 0.015mg/day		Ring	1,052,229 L.L
A02BC05	NEXIUM	B	Esomeprazole sodium - 40mg	40mg	Injectable powder for solution	5,254,424 L.L
A02BC05	NEXPRAZOL 20	G	Esomeprazole - 20mg	20mg	Tablet, enteric coated	275,168 L.L
A02BC05	NEXIUM	B	Esomeprazole (magnesium trihydrate) - 40mg	40mg	Tablet, enteric coated	1,138,235 L.L
A02BC05	NEXIUM	B	Esomeprazole (magnesium trihydrate) - 40mg	40mg	Tablet, enteric coated	1,138,235 L.L